Concepedia

Mathias Gehrmann

MG

30

Publications

3.7K

Citations

26

H-Index

2001

Active since

Affiliations

Johannes Gutenberg University Mainz(Current)

TU Dortmund University

Leibniz Research Centre for Working Environment and Human Factors

Bayer (Germany)

University Medical Center of the Johannes Gutenberg University Mainz

Mathias Gehrmann is an author at Johannes Gutenberg University Mainz specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2001–2022

30

Publications

30

The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer

Marcus Schmidt, Daniel Böhm, Christian von Törne et al. · Cancer Research · 2008 · 825 citations · Full text

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Martin Filipits, Margaretha Rudas, R. Jakesz et al. · Clinical Cancer Research · 2011 · 703 citations · Full text

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors

Marcus Schmidt, Birte Hellwig, Seddik Hammad et al. · Clinical Cancer Research · 2012 · 258 citations · Full text

Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer

Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt et al. · Breast Cancer Research · 2010 · 218 citations · Full text

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Peter Dubsky, Martin Filipits, R. Jakesz et al. · Annals of Oncology · 2012 · 212 citations

Rows per page

1–5 of 30